EDGAR Filing Documents for 0001437749-23-011528

Form 8-K - Current report:

SEC Accession No. 0001437749-23-011528

Filing Date

2023-04-28

Accepted

2023-04-28 10:56:28

Documents

Period of Report

2023-04-25

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	navb20230427_8k.htm iXBRL	8-K	45347
2	EXHIBIT 5.1	ex_509181.htm	EX-5.1	7871
3	EXHIBIT 10.1	ex_509182.htm	EX-10.1	522499
4	EXHIBIT 10.2	ex_509183.htm	EX-10.2	173585
5	EXHIBIT 10.3	ex_509184.htm	EX-10.3	19077
6	EXHIBIT 10.4	ex_509185.htm	EX-10.4	8319
7	EXHIBIT 99.1	ex_509187.htm	EX-99.1	12302
12		maslon.jpg	GRAPHIC	2011
	Complete submission text file	0001437749-23-011528.txt		1082944

Data Files

Seq	Description	Document	Type	Size
8	XBRL TAXONOMY EXTENSION SCHEMA	navb-20230425.xsd	EX-101.SCH	4035
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	navb-20230425_def.xml	EX-101.DEF	13506
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	navb-20230425_lab.xml	EX-101.LAB	17660
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	navb-20230425_pre.xml	EX-101.PRE	13473
14	EXTRACTED XBRL INSTANCE DOCUMENT	navb20230427_8k_htm.xml	XML	4280

Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017

Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500

NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)